Stay updated on Sasanlimab in Advanced Malignancies Clinical Trial
Sign up to get notified when there's something new on the Sasanlimab in Advanced Malignancies Clinical Trial page.

Latest updates to the Sasanlimab in Advanced Malignancies Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page continues to display a 403 Forbidden error instead of the clinical-trial record. A general NIH website transition notice has been added, and the site revision advances to v3.7.2.SummaryDifference1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier updates from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check33 days agoChange DetectedThe page previously displayed a 403 error and now shows the actual study details content for the NCT04181788 record, restoring access to the ClinicalTrials.gov entry.SummaryDifference0.5%

- Check40 days agoChange DetectedA 403 Forbidden page now appears at the study URL, replacing the study record and its associated details. The visible content shifts to the error notice and site footer, signaling restricted access to the study information.SummaryDifference18%

- Check47 days agoChange DetectedThe page now displays Revision: v3.7.0, replacing the previous Revision: v3.6.6. This update appears to reflect a version control change rather than any clinical trial details.SummaryDifference0.0%

- Check61 days agoChange DetectedAddition of Revision: v3.6.6 and removal of Revision: v3.6.5, signaling an updated revision entry on the page.SummaryDifference0.0%

Stay in the know with updates to Sasanlimab in Advanced Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sasanlimab in Advanced Malignancies Clinical Trial page.